NF-kappaB Activation in Light-induced Retinal Degeneration in a Mouse Model
Overview
Affiliations
Purpose: To investigate the modulation of nuclear factor (NF)-kappaB in light-induced photoreceptor degeneration in a mouse model.
Methods: Mice were exposed to intense green light. Light-induced activation of NF-kappaB and its nuclear localization were studied by immunohistochemistry. The NF-kappaB DNA-binding activity in the retinas after exposure to light was measured by electrophoretic mobility shift assay (EMSA). Nuclear transactivation of NF-kappaB in the photoreceptor cells was determined by quantitative real-time (qRT)-PCR. The amount of NF-kappaB p65 in the photoreceptor cells after exposure to light was assessed by Western blot analysis. To obtain more photoreceptor-specific information, microdissected photoreceptor cells were used in some studies.
Results: By an immunohistochemical method, the perinuclear region of the photoreceptor cells was heavily labeled with an antibody to activated NF-kappaB after a 1-hour exposure to light. Nuclear localization of NF-kappaB in the photoreceptor nucleus was seen at 12 hours. In the experiments involving 3 hours of exposure to light followed by recovery in the dark, nuclear localization of NF-kappaB was also noted after 12 hours' recovery in the dark. During continuous exposure to light, the NF-kappaB DNA-binding activity gradually increased and reached its maximum at 12 hours. There was an increase of NF-kappaB p65 protein at 3 hours. The mRNA levels of IkappaBalpha were upregulated after 6 hours' exposure to light.
Conclusions: Intense light activated NF-kappaB in the photoreceptor cells in vivo, increased the NF-kappaB DNA-binding activity, and increased the expression of mRNA of IkappaBalpha, a target gene of NF-kappaB.
Varner L, Chaya T, Maeda Y, Tsutsumi R, Zhou S, Tsujii T iScience. 2024; 27(4):109380.
PMID: 38510130 PMC: 10951987. DOI: 10.1016/j.isci.2024.109380.
Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation.
Wang X, Wang T, Lam E, Alvarez D, Sun Y Int J Mol Sci. 2023; 24(15).
PMID: 37569464 PMC: 10418793. DOI: 10.3390/ijms241512090.
GSK3 Is a Central Player in Retinal Degenerative Diseases but a Challenging Therapeutic Target.
Hottin C, Perron M, Roger J Cells. 2022; 11(18).
PMID: 36139472 PMC: 9496697. DOI: 10.3390/cells11182898.
Mahmud N, Paraoan L, Khaliddin N, Kamalden T Front Cell Neurosci. 2022; 16:786926.
PMID: 35308121 PMC: 8924063. DOI: 10.3389/fncel.2022.786926.
Kutsyr O, Noailles A, Martinez-Gil N, Maestre-Carballa L, Martinez-Garcia M, Maneu V Proc Natl Acad Sci U S A. 2021; 118(43).
PMID: 34667124 PMC: 8639377. DOI: 10.1073/pnas.2100566118.